Clinicians have more options at their disposal in the treatment of dry eye disease than ever before, including topical medications and devices.

SYNOPSIS

In this article, we review advances in the treatment of dry eye disease. We will discuss new therapeutic agents including topical lifitegrast and platelet-rich plasma drops. In addition, we will review advances in treatments for meibomian gland dysfunction (MGD) and blepharitis, such as intense pulsed light (IPL), the LipiFlow system, meibomian gland probing, MiBo Thermoflo, Blephex, and the TearCare System. A new device, the Intranasal Tear Neurostimulator, will also be discussed, as well as specialty contact lenses that can be used for the treatment of ocular surface disease, such as Prokera, the PROSE lens, and EyePrintPRO. Finally, we will discuss new medications that are in development.